Skip to main content
Caplight Logo









Humacyte

Humacyte

Public
Durham, North CarolinaBiotechhttps://www.humacyte.com

Humacyte is now publicly traded

The data on this page reflects Humacyte's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Debt

Dec 16, 2025

Total Funding Raised

$696.15M

Company Overview

Humacyte (NAS: HUMA) is a biotechnology company focused on creating universally implantable bioengineered human tissues and organs to enhance patient outcomes and revolutionize medical practices.

Sector

Biotech

AI Layer

Non-AI

Keywords

Human Acellular Vessels (HAVs)Symvess™ bioengineered vascular conduitacellular tissue engineered vessel (ATEV™)universally implantable bioengineered human tissuevascular conduit for extremity arterial injuriesoff-the-shelf vascular grafthuman tissue engineering platformregenerative medical devicevascular repair for trauma centersautologous vein graft alternativehemodialysis access graftcommercial-stage biotechnology platformBiovascular Pancreas™ for Type 1 diabetes

Humacyte Comparables

Compare Humacyte with similar companies based on industry and business-model similarity.

Humacyte comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CorMatrix Cardiovascular, Inc.
79%
Xeltis
77%
Vascudyne
74%

Humacyte Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtDec 16, 2025
Private PlacementOct 8, 2025
DebtMay 12, 2023
Reverse MergerAug 26, 2021
StrategicJun 11, 2018
Grant
Sep 28, 2017

Humacyte Investors

Notable investors and investment history

Humacyte Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Humacyte Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range186
Year Founded2004
Last FundingDec 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?